Evidence map›Paper›PMID 25942462›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2015

Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.

Maya L Petersen, Erin LeDell, Joshua Schwab, Varada Sarovar, Robert Gross, Nancy Reynolds, Jessica E Haberer, Kathy Goggin, Carol Golin, Julia Arnsten and 9 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Practical Considerations for Variable Screening in the Super Learner.The New England Journal of Statistics in Data Science · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. MISL: Multiple imputation by super learning.Statistical methods in medical research · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Economic evaluations of big data analytics for clinical decision-making: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Maya L Petersen*Division of Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA; †Departments of Medicine (Infectious Disease) and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ‡School of Nursing, Yale University, New Haven, CT; §Massachusetts General Hospital, Center for Global Health, Harvard Medical School, Boston, MA; ‖Health Services and Outcomes Research, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City Schools of Medicine and Pharmacy, Kansas City, MO; ¶Departments of Health Behavior and Medicine, School of Medicine and Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC; #Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY; **Department of Psychiatry, School of Medicine, Yale University, New Haven, CT; ††HIV Center for Clinical and Behavioral Studies, NY State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, NY; ‡‡Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, RI; §§Department of Psychology, University of Washington, Seattle, WA; ‖‖Department of Health and Community Systems, University of Pittsburgh, School of Nursing, Pittsburgh, PA; ¶¶School of Dentistry, University of California, Los Angeles, Los Angeles, CA; and ##Massachusetts General Hospital, Center for Global Health, Department of Global Health and Population, Harvard School of Public Health, Boston, MA.
Erin LeDell
Joshua Schwab
Varada Sarovar
Robert Gross
Nancy Reynolds
Jessica E Haberer
Kathy Goggin
Carol Golin
Julia Arnsten
Marc I Rosen
Robert H Remien
David Etoori
Ira B Wilson
Jane M Simoni
Judith A Erlen
Mark J van der Laan
Honghu Liu
David R Bangsberg

Funding

WOMEN'S HEALTH AGENDAU01AI038858 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI BENSON, CONSTANCE ANN · 1996 to 2008
$157.5M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI John Edward Pachankis · 2001 to 2026
$48.5M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2003 to 2026
$48.2M
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials UnitUM1AI069419 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 2012 to 2026
$44.6M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
HIV-1, ETHNICITY, GENDER AND ACUTE STRESS REACTIVITYP01MH049548 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ANTONI, MICHAEL HOWARD · 1993 to 2002
$8.5M
Targeted Learning using adaptive designs for HIV Epidemic control in East AfricaR01AI074345 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PETERSEN, MAYA LIV, VANDERLAAN, MARK J · 2007 to 2023
$6.6M
Cornell Clinical Trials UnitU01AI069419 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI GULICK, ROY M. · 2007 to 2011
$6.5M
Improving Adherence to Antiretroviral TherapyR01NR004749 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ERLEN, JUDITH A · 1998 to 2007
$3.6M
CDC HHS CC02-SD-003CDC HHS CC99-SD003NIAID NIH HHS AI069419NIAID NIH HHS AI38858NIAID NIH HHS P30 AI042853NIAID NIH HHS P30 AI045008NIAID NIH HHS P30 AI050410NIAID NIH HHS P30-AI50410NIAID NIH HHS R01 AI074345NIAID NIH HHS R01AI41413NIAID NIH HHS U01 AI038858NIAID NIH HHS U01 AI069419NIAID NIH HHS UM1 AI069419NIDA NIH HHS K02 DA017277NIDA NIH HHS K02DA017277NIDA NIH HHS R01 DA013826NIDA NIH HHS R01 DA015215NIDA NIH HHS R01 DA015679NIDA NIH HHS R01DA015679NIDA NIH HHS R01DA11869NIDA NIH HHS R01DA13826NIDA NIH HHS R01DA15215NIMH NIH HHS K08 MH001584NIMH NIH HHS K08 MH01584NIMH NIH HHS K23MH01862NIMH NIH HHS K23 MH087228NIMH NIH HHS K23MH087228NIMH NIH HHS K24 MH092242NIMH NIH HHS P01MH49548NIMH NIH HHS P30 MH043520NIMH NIH HHS P30 MH062294NIMH NIH HHS R01 MH054907NIMH NIH HHS R01 MH058986NIMH NIH HHS R01 MH061173NIMH NIH HHS R01 MH061695NIMH NIH HHS R01 MH068197NIMH NIH HHS R01MH068197NIMH NIH HHS R01 MH078773NIMH NIH HHS R01MH078773NIMH NIH HHS R01MH54907NIMH NIH HHS R01MH58986NIMH NIH HHS R01MH61173NIMH NIH HHS R01MH61695NINR NIH HHS R01 NR004749NINR NIH HHS R01NR04749
6 · The paper itself

Abstract

objectiveRegular HIV RNA testing for all HIV-positive patients on antiretroviral therapy (ART) is expensive and has low yield since most tests are undetectable. Selective testing of those at higher risk of failure may improve efficiency. We investigated whether a novel analysis of adherence data could correctly classify virological failure and potentially inform a selective testing strategy.

designMultisite prospective cohort consortium.

methodsWe evaluated longitudinal data on 1478 adult patients treated with ART and monitored using the Medication Event Monitoring System (MEMS) in 16 US cohorts contributing to the MACH14 consortium. Because the relationship between adherence and virological failure is complex and heterogeneous, we applied a machine-learning algorithm (Super Learner) to build a model for classifying failure and evaluated its performance using cross-validation.

resultsApplication of the Super Learner algorithm to MEMS data, combined with data on CD4 T-cell counts and ART regimen, significantly improved classification of virological failure over a single MEMS adherence measure. Area under the receiver operating characteristic curve, evaluated on data not used in model fitting, was 0.78 (95% confidence interval: 0.75 to 0.80) and 0.79 (95% confidence interval: 0.76 to 0.81) for failure defined as single HIV RNA level >1000 copies per milliliter or >400 copies per milliliter, respectively. Our results suggest that 25%-31% of viral load tests could be avoided while maintaining sensitivity for failure detection at or above 95%, for a cost savings of $16-$29 per person-month.

conclusionsOur findings provide initial proof of concept for the potential use of electronic medication adherence data to reduce costs through behavior-driven HIV RNA testing.

Indexed as

Artificial IntelligenceDecision Support TechniquesDrug MonitoringAdultAnti-HIV AgentsCohort StudiesFemaleHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesRNA, ViralTreatment FailureAnti-HIV AgentsRNA, Viral

Identifiers

PMID25942462
PMCPMC4421909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.